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Ukraine is one of the five countries in the WHO European region with the lowest life expectancy (11 years 
less than in the EU) and more than 10 ǇĞĂƌƐ ?ůŝĨĞĞǆƉĞĐƚĂŶĐǇŐĂƉďĞƚǁĞĞŶŵĂůĞƐĂŶĚĨĞŵĂůĞƐ ?t,K ? ? ? ? ? ?
The leading causes of mortality and morbidity include such conditions as CVD, stroke, COPD, cancers, 
,/s ?/^ ?ĐĐŽƌĚŝŶŐƚŽhŬƌĂŝŶĞ ?Ɛ^ƚĂƚŝƐƚŝĐĂůŽĨĨŝĐĞ ?ƚŚĞǇĐĂƵƐĞĂƉƉƌŽǆŝŵĂƚĞůǇ ? ?A?ŽĨĂůůĚeaths (World Bank 
2009). These conditions are considered to be avoidable given the current state of medical knowledge and 
technology (Castelli and Nizalova 2011), but mainly require effective functioning of an integrated Public 
Health (PH) system, encompassing, among other things, disease prevention and health promotion. 
This working paper describes briefly the situation in Ukraine in terms of population health over the past 
decade, starting from the analysis of the national level data on mortality and comparison of its levels and the 
ůĂƐƚĚĞĐĂĚĞ ?ƐĚǇŶĂŵŝĐƐƚŽƚŚĂƚŝŶƚŚĞh< ?ƐƚŽŶŝĂ ?ĂŶĚZƵƐƐŝĂ ?&ƵƌƚŚĞƌĐŽŵƉĂƌŝƐŽŶŝƐŵĂĚĞďĞƚǁĞĞŶ
avoidable/non-avoidable mortality as a more appropriate measure of the effectiveness of the Public Health 
system. To complete the description of the situation with population health, we analyse the available 
information on morbidity across various conditions linked to high mortality. 
Chapter 1: Mortality 
Although Ukraine is geographically part of Europe, it is lagging far behind both Eastern and Western 
European countries, occupying second place in the world in terms of the number of deaths per thousand of 
population (15.72 in 2014)1: between South Africa (17.49) and Lesotho (14.91) while the EU average 
fluctuates around 10. In this section, we analyse position of Ukraine on mortality statistics as a final measure 
of population health, using Estonia, Russia, and the UK as comparison countries. Both Estonia and Russia 
share common institutional past with Ukraine and they were at the same levels in terms of mortality at the 
time of the Soviet Union breakout. Unlike Ukraine and Russia, Estonia is one of the three post-Soviet Baltic 
states which joined the EU and have shown remarkable convergence to the Western world on a number of 
outcomes, including health. The UK has been chosen for two reasons. First, it is one of the few developed 
economies with the healthcare system, which is free at the point of delivery, similar to the countries of the 
Former Soviet Union. Second, it has consistently been ranked among the top, and 1st in the most recent 
ranking, among the wealthiest countries in the world with the quality of care, access to care, and efficiency 
being the determining factors (Davis et al. 2014). We only focus on the most recent years available in the 
WHO Mortality Database (MDB)2 starting from the period when all the considered country switch to 
reporting based on comparable ICD-10 coding. 
Figure 1 below shows the dynamics of the crude death rate for men and women separately. As can be seen, 
from year 2004 Ukraine has shown more or less similar downward trend to the comparison countries, albeit 
at consistently higher level of mortality rates. The gap between male and female mortality is striking with 
the female mortality rate at the beginning of the considered period being equal to the male mortality rate at 
the end of the period. Only UK is showing more or less equal situation for men and women when examining 
the crude mortality rate.  
                                                          
1 http://www.indexmundi.com/g/r.aspx?c=up&v=26  
2 Accessed at http://www.who.int/healthinfo/mortality_data/en/ on June 30, 2016. The analyses, 
interpretations and conclusions resulting from the use of the MDB are responsibility of the authors 
data and not the WHO, which is responsible only for the provision of the original information. 
ĞŝŶŐĂǁĂƌĞŽĨƚŚĞůŝŵŝƚĂƚŝŽŶƐŽĨƚŚĞĐŽŵƉĂƌŝƐŽŶƐďĂƐĞĚŽŶƚŚĞĐƌƵĚĞŵŽƌƚĂůŝƚǇƌĂƚĞƐĚƵĞƚŽƚŚĞĐŽƵŶƚƌŝĞƐ ?
differences in age and gender structure, the analysis which follows is making use of the age and gender 
standardization based on the European Standard Population (2013).  
The comparison of crude deaths rates can actually be very misleading because of the differences in age 
distribution across countries, over time and between males and females. We apply the European Standard 
Population (ESP) 2013 developed by the Eurostat Taskforce (2013) to achieve proper comparison, using the 
template developed by the Office of National Statistics.3 We also calculate the rates per 100,000 population 
to bring them in correspondence with the analysis that follows. Figure 2 illustrates the differences when 
weighted by the ESP 2013. As could be seen, the age standardised mortality rates are much higher for males 
than the crude mortality rates, while the difference is less dramatic for women. After standardization, there 
is virtually no difference in the mortality rates for women between Russia and Ukraine. However, the 
differences between Ukraine and the UK and Estonia have become greater. For example, in 2012, the last 
year when the data for all three countries is available, male mortality in Ukraine is 120% higher than that in 
the UK and 40% higher than in Estonia. For females, the difference is less dramatic with females likelihood of 
death in Ukraine being 68% higher than in the UK and 55% higher compared to Estonia. At the same time 
within country differences between males and females show a different pattern: the most striking difference 
in 2012 is observed in Estonia with males being 92% more likely to die than females, while the corresponding 
number is 73% for Ukraine and 32% for the UK. 
 
Figure 1 Crude Death Rate (per 1,000 population) 
 
                                                          
3 Accessed online at http://www.ons.gov.uk/ons/guide-method/user-guidance/health-and-life-





































 Figure 2 Age and Gender Standardized Mortality Rates (per 100,000 population) 
 
There are a number of factors which can potentially explain such a difference in the age standardised 
mortality rates across countries, ranging from distant ones, such as macro-economic, ecological, socio-
cultural, organization of health care system, to proximate such as health affecting behaviours, income, 
stressful events, hereditary risk factors, as well as the use of health care. Although ultimately any premature 
death can be considered as a failure of the Public Health system, it is instructive to start with the analysis of 
a number of causes which could have been avoided via proper and timely health care intervention or 









ZƵƚƐƚĞŝŶ ?ƐĞƚĂů ? ? ? ? ? ? ?ŽƌŝŐŝŶĂůůŝƐƚŽĨƵŶƚŝŵĞůǇĚŝƐĞĂƐĞƐ ?ĚŝƐĂďŝůŝƚǇĂŶĚĚĞĂƚŚŚĂƐďĞĞŶƌĞǀŝƐĞĚƐĞǀĞƌĂůƚŝŵĞƐ
to take into account advances in medical care as well as to incorporate changes made to the coding of 
causes of deaths (ICD codes) (Charlton et al. 1983, Holland 1986, Nolte and McKee 2004). The concept was 
later broadened to include causes preventable not only via medical intervention but also via public policies 

































Avoidable mortality: causes of deaths that are considered amenable 
to both medical intervention and health policy. 
Treatable causes or medical care indicators (MCI): causes of deaths 
amenable to medical intervention only. 
Preventable causes or health policy indicators (HPI): causes of death 
that are amenable to health policy only. 
The concept of avoidable mortality refers, therefore, to all those deaths that, given current medical 
knowledge and technology, could be avoided by the healthcare system through either prevention and/or 
treatment. The remainder of deaths include those which cannot be avoided, either by the terminal nature of 
the disease for which there is no known cure, or due to very old age, or due to an accident for which no 
policy could be devised. 
Avoidable mortality indicator (AM) is constructed from the WHO Mortality database death counts from 
specific causes per 100 thousand population. We combine the list of causes from Nolte and McKee (2004) 
and Page et al. (2006) (See Table A.1 in Castelli and Nizalova (2011)).  
 
 
Figure 3 Avoidable Mortality in Ukraine per 100,000 population 
 
Figure 3 shows age and gender standardised avoidable mortality rates over the considered period. As could 
be seen deaths which can be avoided are much smaller than the total mortality shown in Figure 2. Several 
observations are worth mentioning with respect to these graphs. First of all, in spite all the difficulties which 
the country has been experiencing, there is a clear downward trend in avoidable mortality. Second, the 
decline in sharper for males than for females. Finally, the gender gap in avoidable mortality in 2012 is much 
larger than that in total mortality: avoidable mortality is 137% for men than for women while the difference 
in total mortality is only 73%. This points to a significant difference in effectiveness of existing healthcare 
system and public health policies in improving health of men when compared to women.  
To put things into perspective it is instructive to compare the ratio of avoidable mortality rates to total 
mortality rates in dynamics and to those in the United Kingdom, as a country which is regarded as having 
one of the best healthcare systems in the world. As is evident from Figure 4, Ukraine lags far behind in terms 
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avoidable deaths for males in Ukraine has been quite stable, showing a slight decrease in Russia and Estonia 
and a significant decrease in the UK. This resulted in an increasing gap between the countries: the share of 
avoidable deaths among all death amounted to 33.3% among males in Ukraine while only to 15.9% in the UK 
(the respective numbers for females are 23% and 11%). 
 
 
Figure 4 Share of avoidable mortality in total mortality. 
 
In terms of the mortality breakdown by cause, diseases of the circulatory system are leading the chart. In 
this perspective, Ukraine shows a similar trend to the developed countries (see Table 1). Overall, the diseases 
in this category account for 67% of all deaths. Neoplasms (mainly malignant neoplasms) are on the second 
place among the causes of mortality, leading to 13% of deaths. External causes refer to 6.3%, diseases of the 
digestive system cause 4% of deaths, and diseases of the respiratory system constitute 2.3%. Certain 
infectious and parasitic diseases are on the sixth place by causes of death. This refers to the Tuberculosis and 
the HIV infection. Although, the TB and the HIV death rates decreased somewhat in recent years, these 
epidemics still are of major concern. To summarize, the overall distribution of deaths shows a great burden 
of non-communicable diseases (NCDs), as in the developed countries, but also a continued concern with 































Table 1: Crude mortality rates by cause of death in 2014 (per 100,000) 
Causes of death 2014 % of total 
All causes 1470.4 100.0% 
Diseases of the circulatory system  989.8 67.3% 
Neoplasms  195.1 13.3% 
Diseases of the digestive system  58.7 4.0% 
Diseases of the respiratory system  34.4 2.3% 
Certain infectious and parasitic diseases , incl.  25.5 1.7% 
Tuberculosis 12.2 0.8% 
HIV 10.2 0.7% 
Diseases of the nervous system  
 
13.7 0.9% 
Endocrine, nutritional and metabolic diseases  5.2 0.4% 
Diseases of the genitourinary system  6.3 0.4% 
Certain conditions originating in the perinatal period  4.6 0.3% 
Mental and behavioural disorders  3.7 0.3% 
Congenital malformations, deformations and chromosomal 
abnormalities  3.5 0.2% 
Diseases of the skin and subcutaneous tissue  1.2 0.1% 
Diseases of the musculoskeletal system and connective tissue  1.2 0.1% 
Pregnancy, childbirth and the puerperium  0.2 0.0% 
Diseases of the blood and blood-forming organs and certain 
disorders involving the immune mechanism  0.6 0.0% 
Symptoms, signs and abnormal clinical and laboratory findings, 
not elsewhere classified  33.5 2.3% 
External causes 93.3 6.3% 
Source: UISS, 2016. 
Chapter 2: Morbidity 
The most frequent diseases among adult population are respiratory diseases (44% in total incidence), 
diseases of circulatory system (6.9%), urogenital diseases (6.6%), injury, poisoning and certain other 
consequences of external causes (6.3%), skin and subcutaneous tissue (5.8%) etc. (SSSU 2016). In the 
following, we focus on the diseases, which are the main causes of mortality and constitute main health 
issues. 
Diseases of the circulatory system 
Diseases of the circulatory system are the most widespread among non-infection diseases in the country. 
The prevalence rate constituted 52,957 cases per 100,000 people in 2015 and the rate increased 2.7 times 
since 1991 (UISS under the Ministry of Health, 2016). The latter can be also explained by better diagnostics 
and higher completeness of exposure. Over the last 10 years the dynamics is more positive, the incidence 
rate decreased from 5179 in 2005 to 4979 in 2013 and 4321 in 20154 (SSSU, 2016). According to the 
t,K ?ƐƵƌŽƉĞĂŶ,ĞĂůth for All Database (HFA-DB, 2016) age-standardized death rate amounted to 674 cases 
per 100,000 people in 2014, which is more than 3 times higher compared to the EU average of 192. The 
                                                          
4 The improvement in the incidence and prevalence dynamics in 2014-2015 should be treated with 
caution due to the lack of information from temporarily occupied territories of Ukraine 
most widespread conditions by incidence rate are hypertensive diseases (39%), ischaemic heart 
diseases(27%), and cerebrovascular diseases (17%) (UISS, 2016). 
Cancer 
The estimated age-standardised (European) incidence rate from all sites but non-melanoma skin cancer was 
260.4 per 100,000 in 2012, compared to the EU average of 378.5 (Ferlay at al., 2013), though the difference 
is unlikely to mean more favorable situation, but being mostly an indication of poor diagnostics. The ratio of 
mortality to incidence based on age-standardized data of International Agency for Research on Cancer 
amounted to 61% for Ukraine and only 48% for the EU. One of the reasons for that is the late diagnosis. Only 
54% of all cancer cases are diagnosed at the 1-2 stage in Ukraine (NCRU, 2016). Over 20% of female breast 
cancer and 58-60% of ovarian cancer cases are diagnosed at advanced stages. The corresponding EU or US 
numbers are 5-7% (UISS, 2016). In most recent 2014-2015 years the dynamics is more positive. Still, the risk 
of having cancer during a lifetime is 28% for men and 18% for women (UISS, 2016). The most frequent for 
males are cases of trachea, bronchus and lungs (16%), colorectal (12%) skin (10%) and prostate cancer (10%), 
while breast (20%), skin (13%), colorectal (12%), uterine (9%) and cervical (6%) malignant neoplasms are 
most widespread for females. 
The cancer incidence rates for children aged 0-17 are much lower compared to the adult population and 
constitute 15.6 cases per 100,000 in 2014 according to the National Cancer Registry of Ukraine. However, 
these incidence rates are increasing. For instance, the correspondent rate in 2007 constituted 12.7. The most 
frequent are leucosis, lymphoma, and malignant neoplasm of other and unspecified parts of nervous system. 
Diabetes mellitus 
The global diabetes mellitus prevalence rate is rising. The main dangers of this disease are serious 
complications, which include cardiovascular diseases, kidney, foot and eye complications, etc. Dynamics of 
this indicator in Ukraine is in line with the global patterns. So far, diabetes mellitus prevalence rate is 43% 
lower compared to the EU average: 2.89% in Ukraine compared to 3.76% for the European region and 5.09% 
for the EU in 2012(HFA-DB, 2016). The International Diabetes Federation estimates that there is a significant 
underdiagnosis in this regard. Age-adjusted prevalence at age 20-79 is 6.5% for Ukraine compared to 7.3% 
for Europe on average5. Despite relatively lower incidence rates, the numbers are growing. In 2013 the 
incidence rate was 60% higher than 10 years before that. 
Infectious diseases 
HIV 
The HIV incidence rate is among the highest in the European region and an increase in incidence rates is 
even more alarming. The HIV incidence rate, which is drastically higher compared to the EU average (36.88 
vs. 5.85 per 100,000 in 2014), increased by 230% since 2000 (HFA-DB, 2016). Even more striking is the 
progress of HIV infection into AIDS. The AIDS incidence rates constituted 22.98 compared to 0.8 in EU, which 
is an indication of an ineffective HIV treatment. The estimated prevalence rate among people aged 15 and 
above amounted to 0.58% at the beginning of 2015 (UNAIDS, UCDC, 2015). A large share of all HIV cases 
remains undetected in Ukraine. According to the UNAIDS/ UCDC report (2015), only 60% of estimated HIV 
                                                          
5 International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 
2015. Accessed online at http://www.diabetesatlas.org/ on November 26, 2016 
 
cases were registered. Regarding transmission mechanisms, there is a tendency towards an increase in the 
share of heterosexual contacts in newly registered cases. In 2015, 71% of newly registered cases were 
transmitted through heterosexual contacts and 26% through injecting drug use. The number of children born 
from infected mothers constituted 2,958 in 2015, which is almost 19% of total registered cases. The majority 
of these children will lose HIV maternal antibodies after 18 months and will not be infected by the HIV. The 
frequency rate of mother-to-child transmission of the HIV reduced from 27,8% in 2001 to 3,35% in 2014 
(UCDC, 2016a).  
Tuberculosis 
According to the WHO definition, Ukraine has tuberculosis epidemics with a registered prevalence rate of 90 
per 100,000 (UISS, 2016) and estimated prevalence rate of 114 in 2014 (HFA-DB, 2016). The growth in the TB 
incidence stopped in 2004 and incidence rates started to decline since 2007. Despite improved dynamics, 
Ukraine is far from combating the disease. The first issue is the expansion of multidrug-resistant tuberculosis 
due to insufficient treatment of the disease in previous years. According to 2014 data Ukraine was among 
the top-5 countries with multidrug-resistant tuberculosis (Global tuberculosis report, 2016). Another 
pertinent issue is the TB and HIV co-infection. The incidence rate of the TB and HIV co-infection is 13.0 per 
100,000 which is 18% of all TB cases (UISS, 2016). 
Maternal health 
Though maternal death rate decreased from 30 per 100,000 in 1991 to 14.81 in 2014 (HFA-DB, 2016), there 
is no stable downward trend. For instance, before falling to 14.81 in 2014, the rate decreased to 13 in 2004 
and then went up to 25 in 2009. Compared to the EU average, maternal death rate in Ukraine is three times 
higher. Perinatal death rate constituted 8.6 in Ukraine compared to 6.09 in the EU on average in 2014 and 
neonatal death amounted to 3.4 and 2.52 respectively. Despite the overall negative situation, several 
improvements had taken place. The implementation of the evidence-based medicine and clinical pathways 
allowed decreasing the number of obstructed labour from 63% in 2004 to 32% in 2015 (UISS, 2016). 
However, the rate of Caesarean sections increased from 16.0% in 2010 to 18.5% in 2015, while, according to 
ƚŚĞt,K^ƚĂƚĞŵĞŶƚŽŶĂĞƐĂƌĞĂŶ^ĞĐƚŝŽŶZĂƚĞƐ ?t,K ?,ZW ? ? ? ? ?  ƚŚĞ “ĐĂĞƐĂƌĞĂŶƐĞĐƚŝŽŶƌĂƚĞƐŚŝŐŚĞƌƚŚĂŶ
10% are not associated with ƌĞĚƵĐƚŝŽŶƐŝŶŵĂƚĞƌŶĂůĂŶĚŶĞǁďŽƌŶŵŽƌƚĂůŝƚǇƌĂƚĞƐ ? (p. 4). At the same time, 
the Ukrainian figures are substantially lower compared to the EU average of 27.4% (HFA-DB, 2016). 
Historically, the number of abortions had been higher than the number of live births since Soviet times in 
Ukraine. The situation reversed in 2001 and the rate of abortions decreased further to 25.66 per 100 live 
births in 2015 (UISS, 2016). The ratio of safe to unsafe abortions improved from 3.5 in 2011 to 5.9 in 2015. 
Children health 
Infant mortality rates are lower compared to most of the CIS countries, but still are twice as high as the 
average EU rate: 7.85 compared to 3.69 per 1000 live birth in 2014 (HFA-DB, 2016). The probability of dying 
before age 5 is more than twice higher as well: 7.85 vs. 3.69 per 1000 live birth. 
As for general incidence rates, the most frequent diseases were respiratory system diseases (69% in total 
incidence), skin and subcutaneous tissues diseases (4.9%), certain infectious and parasitic diseases (3.7%), 
injury, poisoning and certain other consequences of external causes (3.6%), digestive system diseases (3.4%), 
etc. (SSSU, 2016). 
Immunization is one of the most problematic issues since the immunization coverage ratio in Ukraine is 
among the lowest in the world. Only 45% of newborns were vaccinated against tuberculosis in 2015, only 
42% of children of the first year of life were vaccinated against diphtheria and tetanus, 43% against 
whooping cough, 68% against poliomyelitis, 42% against hepatitis B (SSSU, 2016). As a result of the low 
immunization coverage rates, two cases of vaccine-derived polio were registered in 2015, both in non-
vaccinated children. The main reasons for low immunization coverage are related to the shortages in the 
supply of vaccines and distrust towards vaccinations among the population. 
 
Chapter 2: Spatial Inequalities in Health 
The analysis of both country level mortality and morbidity data has shown some positive trends towards 
improvement of population health. Although the speed of this improvement has been quite slow to allow for 
a meaningful convergence with the Western countries. A significant health inequality between men and 
women has been detected and this sub-section takes the analysis further by exploring the spatial aspects of 
the data, analysing it by geographic location and the degree of rurality. Here we rely on a database of 
mortality and morbidity collected from the Oblast Centres of Medical Statistics. The quality and scope of the 
data will be discussed later in Chapter 7.  
Ukraine is divided into 27 territorial entities: 24 oblasts, one Autonomous Republic of Crimea, and 2 cities 
with special status (Kyiv and Sebastopol). Each oblast is subdivided into rayons and cities (settlements with 
more than 10,000 inhabitants). The smallest feasible level of spatial disaggregation in the health related data 
is at the rayon level. While the country level data allows us to see the overall status in the country, the 
rayon-level data provides an opportunity to investigate whether there is a significant variation in the 
indicators and, consequently, if there is any specific group which may be considered vulnerable and would 
require more attention in the programmes/project design and evaluation. Since the start of the Russian 
annexation of Crimea and invasion to Donetsk and Luhansk oblasts, the data from these regions is not being 
collected and therefore they are excluded from the analysis in the report. Table 2Error! Reference source 
not found. uses the data for the first and the last available years  W 2008 and 2015  W to analyse both the 
geographic variation and the time dynamics. 
Analysing first the total mortality, we see that it has somewhat improved over time. Yet, there is still a 
significant variation across rayons  W the standard deviation is larger than 10% of the magnitude of the mean 
total mortality. The lowest observed levels of mortality at the end of the period are still higher than the EU 
average of 10 per 1,000 (or 1,000 per 100,000), while the maximum is more than twice higher than that 
number. There is an even larger variation in the avoidable mortality  W with the standard deviation 
constituting more than 20% of the mean value, both in 2008 and 2015.  
The right panel of the table allows the analysis by gender. As can be seen, total mortality among men is 75% 
larger than that for women in 2008 and 68% larger in 2015, with a significant spatial variation. The situation 
is much worse in what concerns avoidable mortality  W with men having 185% higher indicator than the one 
for women in 2008 and 173% higher in 2015. This evidence clearly shows that men are more vulnerable in 
terms of mortality than women. And the answer lies not only in the socio-economic and environmental 
factors, but also in the healthcare and public health system, as the gender inequality in avoidable mortality is 
striking and requires further investigation on how to improve the reach of males by the existing system. 
 
 
Table 2: Total and Avoidable Mortality based on the rayon level data (per 100,000) 















  (1) (2) (3) (4) (5) (6) 
2008 mean 2061.7  702.4  2772.1*** 1096*** 1581.6*** 385.2*** 
  sd (241.0) (147.3) (384.5) (228.4) (197.2) (99.5) 
  median 2061.8  694.4  2759.9  1087.6  1578.8  373.8  
  min 1400.8  356.6  1667.7  558.1  1009.3  138.1  
  max 3167.7  1538.2  4709.5  2276.6  2378.3  950.1  
  obs. 564 564 564 564 564 564 
2015 mean 1888.9  550.8  2511.2*** 850.3*** 1488.8*** 311.1*** 
  sd (211.3) (111.2) (338.1) (176.5) (172.1) (77.5) 
  median 1888.6  546.9  2490.7  839.5  1479.4  305.6  
  min 1170.0  275.7  1325.3  387.6  911.3  159.7  
  max 2695.8  924.4  3670.0  1506.7  2422.5  752.3  
  obs. 563 563 563 563 563 563 
Note: All mortality rates are age and gender standardised based on the ESP 2013. Stars indicate statistically significant differences between men and 
women in each year: *** 1%, ** 5%, * 10%. 
  
Table 3 adds another dimension to the analysis distinguishing between rural and urban rayons. Cities of 
oblast subordination were considered as urban territories. Other rayons were considered rural. So, 
effectively, rural rayons have either no cities or small urban-type settlements.  
As expected, mortality in rural areas is larger than that in urban areas for both men and women. Moreover, 
the gender inequality in mortality within rural areas is much more pronounced than within urban areas. 
Columns (3) and (6) show the relative size of total mortality among men when compared to women in the 
same areas. In 2008, this meant that mortality among men in urban areas was 69.27% higher than among 
women. Over the 8 years of considered period it does show a decline by 3.6 percentage points, but this 
decline is minuscular compared to the size of inequality. In rural areas the inequality is larger, but it has also 
shown a similar size of decline over the considered period. 
The next table (see Table 4) repeats the analysis in terms of avoidable mortality. In line with the earlier 
observation, the gender inequality in avoidable mortality is much larger than in total mortality. And, 
although it does exhibit a downward trend, the rate of decline in inequality is slightly larger in urban areas 
than it is in rural. So, overall, the analysis of total and avoidable mortality along gender and rurality 
dimensions show that men in rural areas represent the most vulnerable group of population, followed by 
men in urban areas, and women in rural areas. 
  
Table 3: Gender and Rural/Urban dimensions of Total Mortality (per 100,000) 
  












    
relative 
to 





  (1) (2) (3) (4) (5) (6) 
2008  mean 2576.3  1522.0  169.27% 2827.3  1598.5  176.87% 
   sd (450.2) (202.7)   (344.8) (192.6)   
   median 2522.2  1510.5    2806.1  1593.2    
   min 1667.7  1009.3    2022.2  1116.8    
   max 4709.5  2053.5    4393.6  2378.3    
   obs. 124 124   440 440   
2015  mean 2308.4  1392.9  165.73% 2567.9  1515.6  169.43% 
   sd (416.0) (195.0)   (288.9) (155.0)   
   median 2291.0  1388.9    2544.9  1505.0    
   min 1325.3  911.3    1890.2  964.7    
   max 3670.0  1980.5    3433.6  2422.5    
   obs. 123 123   440 440   
Note: All mortality rates are age and gender standardised based on the ESP 2013.  
Table 4: Gender and Rural/Urban dimensions of Avoidable Mortality (per 100,000) 
     Urban Rural 
     Men Women Male mortality  Men Women Male mortality  
         relative to female     relative to female 
   (1) (2) (3) (4) (5) (6) 
2008  mean 945.9  337.2  280.52% 1138.3  398.7  285.55% 




   median 937.3  335.0  
 
1124.2  385.2  
 
   min 558.1  138.1  
 
587.8  208.0  
 
   max 1495.6  616.6  
 
2276.6  950.1  
 




2015  mean 728.0  271.1  268.54% 884.4  322.3  274.40% 




   median 717.5  263.1  
 
869.7  320.2  
 
   min 387.6  163.4  
 
514.8  159.7  
 
   max 1442.7  522.9  
 
1506.7  752.3  
 




Note: All mortality rates are age and gender standardised based on the ESP 2013.  
Figure 5 allows us to document any existing patterns in terms of geographic variation across the larger 
regions of Ukraine. The maps use the same ranges of indicators to allow for both spatial and time 
comparisons. It is evident that at the beginning of the period there is a regional pattern in terms of both 
total and avoidable mortality with the highest values observed in the northern parts of Ukraine, in the 
oblasts bordering Russian Federation, and also the South-North cluster in the East connecting Odesa and 
Kharkiv regions. In 2015 the situation has changed, leaving only few rayons in the same highest range within 
the same larger regions of the country. The lowest mortality cluster is observed in the Western part of the 
country. More detail analysis by gender shows that this is driven by lowest female mortality in the West 
(detailed maps are presented in the Appendix). 
 
In contrast to mortality, documenting spatial patterns in disease burden is much more difficult for several 
reasons. First, any comprehensive measure of the number of morbidities per rayon would be meaningless, 
as it would combine diseases, which are very different by nature. Second, the administrative data on 
diseases includes a large number of indicators and would require a specialised inquiry on the 
appropriateness of any specific indicator, which is beyond the scope of this project. Finally, within this 
project our goal was to scope the data and, therefore, we have had only limited capacity to bring all the 
collected data into a format suitable for statistical analysis. Thus, in this Chapter we have chosen to show 
several selective indicators referring only to two non-communicable conditions  W diabetes and heart 
diseases. The data on mortality in the tables and figures, which follow, is referring to the mortality in 
hospitals and is derived from Form 20 which each hospital fills in. As a result, this may be different from the 
data in the mortality register analysed earlier in this sub-section. 
ůůŚĞĂůƚŚĨĂĐŝůŝƚŝĞƐŵĂŶĂŐĞĚďǇƚŚĞDŝŶŝƐƚƌǇŽĨ,ĞĂůƚŚ ?ƐƵďŵŝƚŵĞĚŝĐĂůƐƚĂƚŝĐƐ&Žƌŵ ? ? ?ĐĂůůĞĚ “ZĞƉŽƌƚŽĨƚŚĞ
ŚĞĂůƚŚĐĂƌĞĨĂĐŝůŝƚǇ ? ?ƚŽƚŚĞ^ƚĂƚĞ^ƚĂƚŝƐƚŝĐƐŽŵŵŝƚƚĞe once a year through a chain of aggregation points. 
First, central hospitals of the respective administrative units (either cities or rajons) collect the data from the 
lower level facilities and submit it to oblast health departments. Than the Form is being aggregated by the 
Ministry of Health and passed further. This Form contains 76 separate tables with statistics on all the 
specialized departments/cabinets of health facilities. Tables of the Form primarily quantify the services that 
were provided by facility and respective health statistics. For further analysis, we work with the Table 3220 
 “Composition of in-patient patients, the timing and outcome of treatment (quantity) ? ? 
  
  




















Avoidable mortality per 100,000 population, 2015
Table 3220 of the Form 20 basically contains 3 indicators distributed by 3 age-groups (Table 5). This data is 
available for 19 major disease classes according to the International Statistical Classification of Diseases and 
Related Health Problems. 
Table 5: Structure of the medical statistics Form 20, Table 3220. 
Age-groups Indicators Disease classes 
1. 18 and older 
2. 0-17 years 
3. Less than 
one year  
1. Number of 
discharged 
patients 
2. Number of bed-
days spent by 
discharged 
patients 
3. Number of 
deaths 
1. Certain infectious or parasitic diseases   
2. Neoplasms   
3. Diseases of the blood or blood-forming organs   
4. Diseases of the immune system, 05 Endocrine, 
nutritional or metabolic diseases   
5. Mental or behavioural disorders   
6. Diseases of the nervous system   
7. Diseases of the eye or ocular adnexa   
8. Diseases of the ear or mastoid process   
9. Diseases of the circulatory system   
10. Diseases of the respiratory system   
11. Diseases of the digestive system   
12. Diseases of the skin   
13. Diseases of the musculoskeletal system or connective 
tissue   
14. Diseases of the genitourinary system   
15. Pregnancy, childbirth or the puerperium   
16. Certain conditions originating in the perinatal or 
neonatal period   
17. Developmental anomalies   
18. Symptoms, signs or clinical findings, not elsewhere 
classified   
19. Injury, poisoning or certain other consequences of 
external causes   
 
In further analysis we use the data for the following disease classes: (i) Diabetes (subsection of the 
Endocrine, nutritional or metabolic diseases), and (ii) aggregated number for Diseases of circulatory system, 
including Acute rheumatic fever, Chronic rheumatic heart diseases, Hypertensive diseases, Ischaemic heart 
disease (including stenocardia, myocardial infarction and other forms of acute ischemic heart disease), 
Cerebrovascular diseases (including intracranial hemorrhage, brain infarction, stroke unspecified, cerebral 
infarction). 
As Figure 6 shows, the number of patients with diabetes discharged from hospitals has been increasing from 
year 2008 till 2013, showing a small decrease afterwards. The dynamics of the number of bed-days almost 
exactly repeats the one on the number of discharged patients, most likely reflecting the standard length of 
the treatment. What is worrying is the dynamics in the number of deaths, which has shown a considerable 
increase over the period from 2010 to 2012. However, a decline was documented from year 2013 to 2014. 
  
 
Figure 6: Number of patients, bed-days spent at hospital and deaths related to diabetes. 
 
Figure 7 shows similar indicators for heart disease. As could be seen, the number of patients discharged from 
hospitals remained relatively stable over the considered period. However, the lengths of their stay seem to 




Figure 7: Number of patients, bed-days spent at hospital and deaths related to heart disease. 
 
Figures Figure 8 and Figure 9 show the spatial distribution of the diabetes and heart disease at the beginning 
and the end of the period.  
  
 
Figure 8. Spatial distribution of number of patients, bed-days spent at hospital and deaths related to diabetes 








Figure 9. Spatial distribution of number of patients, bed-days spent at hospital and deaths related to heart 
diseases in 2008 and 2014. 
 
Most of the indicators for both classes of diseases do not reveal clear regional patterns. However, some 
regional effects are noticeable. For example, the number of discharged patients and the number of bed-days 
spent by the discharged patients with heart disease show distinct regional effects for Kyiv, Chernihiv and 
Dnipropetrovsk oblasts. Similarly, the Right Bank of the Dnipro River and Western part of Ukraine show 
lower rates for both disease classes. Generally, all the maps show significant within and between oblasts 
variation. Standard deviation is quite significant for all the indicators. The maximum values differ from the 
averages approximately by 10 times (Table 6). 
Table 6: Summary statistics for heart diseases and diabetes indicators measures per 100 000 population. 
Country level, 2014 
Statistics 




















Mean         3,617.1                   1.8              298.9         44,243.6              142.6          4,029.2  
Standard   Deviation         2,756.5                   3.5              225.6         22,823.4              120.4          2,061.4  
Median         3,037.4                      0               246.5         39,970.1              122.8          3,656.3  
Min                     0                        0                       0                          0                       0                        0    
Max      29,769.4                 45.9          2,732.7       337,216.1          1,673.8       32,023.9  
N                 506                  500                  506                    508                  508                  508  
 
The variation in indicators also differs across regions. Box plots6 for the number of bed-days spent by 
patients diagnosed with diabetes or heart disease (Figure 10) shed more light on the nature of high maximum 
values. Dots in the box plots show rayons and cities which stand out with very high values of indicators. 
When working with the data, in fact, we could not drop this values considering them outliers: administrative 
units with these high values of indicators have been following the same track during the whole period from 
 ? ? ? ?ƚŽ ? ? ? ? ?ůƚŚŽƵŐŚǁĞĚŽŶ ?ƚŚĂǀĞĞŶŽƵŐŚĞǀŝĚĞŶĐĞƚŽĞǆƉůĂŝŶƚŚĞƐĞĂďŶŽƌŵĂůŝƚŝĞƐ ?ŽŶĞŽĨƚŚĞĨĂĐƚŽƌƐ
likely contributing to this is location of large specialized hospitals in these cities/rayons. (Appendix: Figure 14, 
Figure 15) shows box plots for the rest of the indicators, the situation is consistent across indicators, years 
and oblasts.   
Average administrative unit has 26% - 126% absolute deviation from the average value for the oblast where 
it is located (Table 7).  
Table 7: Average absolute deviation from the oblast mean value. 2014 
Diabetes Heart Diseases 














46 % 126 % 45 % 26 % 44 % 26 % 
 
                                                          
6 Box plot (boxplot, box-and-whiskers plot) is standardized way of displaying the distribution of data based on the five 
number summary: minimum, first quartile, median, third quartile, and maximum. 
  
 




The aim of the chapter was to describe patterns of the population health in Ukraine over the past decade. 
Country level analysis for mortality and morbidity showed some improvement over the recent years. 
However, compared with other countries the speed of this improvement has been quite slow to allow for a 
meaningful convergence with the developed countries, with the age standardised mortality rate remaining 
about twice higher than in the UK, and about 50% higher than in Estonia. The difference between male and 
female mortality continues to be large. In 2012, the age-standardized death rate for males in Ukraine was 
120% higher than in the UK. At the same time, this difference for females was less dramatic  W68%. Apart 
from the total mortality rate, we have also analysed avoidable mortality, i.e. causes of deaths, which are 
considered amenable to medical intervention and health policy. This analysis revealed patterns similar to 
those in total mortality. In spite of a downward trend, which reflects further developments in medical 
technologies and their increasing availability, the gender gap is even more pronounced in avoidable 
mortality. Moreover, among the countries compared in the analysis, Ukraine has the highest share of 
avoidable mortality to total mortality among females, with that among males being on par with Estonia and 
Russia, but much higher than that in the UK. 
The main causes of death in Ukraine are the diseases of the circulatory system (67% of all deaths) and 
neoplasms (13%), while HIV and TB are the main causes of concern among infectious diseases. The diseases 
of the circulatory system are the most widespread among NCDs in the country. As for the neoplasms, the 
incidence rate is lower in Ukraine than in the EU, which is mostly likely due to a poor diagnostics rather than 
more favourable situation. The HIV incidence rate is among the highest in the European region and continue 
to increase. The TB incidence rates have declined since 2007, though the expansion of the multidrug-
resistant tuberculosis remains a concern. Regarding the childhood health, low levels of immunisation 
coverage induced by the distrust of population towards vaccination and shortages of the supply of vaccines 
in previous years raises more and more concerns regarding the future situation with some of the previously 
eradicated infections, such as mumps, rubella, polio, etc. 
In order to investigate the spatial inequalities in health in more detail, we have utilised the rayon-level data, 
which is a smallest feasible level of spatial disaggregation in the health statistics. The mortality analysis at 
rayon level confirms our conclusions at the country level. We admit the improvement in total and avoidable 
mortality, though we observe larger variation between rayons  W more that 10% from the mean. The 
variation in avoidable mortality is even greater  W up to 20% of the mean. We also confirm gender inequality. 
The differences in total and avoidable mortality rates between males and females at rayon level tend to 
decrease. However, the magnitude of the decrease is tiny compared to the level of the difference. As for the 
urban-rural divide, mortality rates in rural areas are larger than that in the urban areas for both men and 
women. Overall, the analysis of total and avoidable mortality along gender and rurality dimensions show 
that men in rural areas represent the most vulnerable group of population, followed by men in urban areas, 
and women in rural areas. 
The disease burden analysis at rayon level has been performed for two classes of diseases: diabetes and 
cardiovascular diseases. For them, we analysed the number of bed-days spent by discharged patients, the 
number of discharged patients and the number of deaths (the latter refer to death which happened in the 
hospital). For these diseases, we do not see a stable downward trend in death rates. In contrast, the death 
rate for diabetes increased in 2008-2013 and slightly diminished in 2014, while the death rate from 
cardiovascular diseases has been on the rise during the whole 2008-2014 period. As for the variation across 
rayons, we observe a significant variation within and between regions. For most of the indicators, regional 
effects are hard to distinguish with few exceptions: lower rates for both classes of diseases in the Western 
part of Ukraine and higher rates for heart diseases for Kyiv, Chernihiv and Dnipropetrovsk oblasts. 
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Figure 15. Box plots of number of discharged patients with the diagnosis related to diabetes and heart 
diseases in 2008 and 2014. 
